News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
169 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (18808)
Month
January (2488)
February (2603)
March (3228)
April (2950)
May (3962)
June (3500)
July (2854)
August (3141)
September (3205)
October (3539)
November (3386)
December (2332)
Day
1 (103)
2 (1)
4 (140)
5 (169)
6 (148)
7 (144)
8 (68)
9 (22)
10 (23)
11 (209)
12 (180)
13 (124)
14 (146)
15 (82)
17 (2)
18 (146)
19 (143)
20 (110)
21 (123)
22 (70)
24 (1)
25 (2)
26 (8)
27 (78)
28 (44)
29 (45)
30 (1)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
10
11
12
13
14
15
17
18
19
20
21
22
24
25
26
27
28
29
30
BioCapital
5 Biotechs With a Whopping 80%+ Buy Rating for Brokers
In an overall good year for pharma and biotech sectors, there have been some standouts.
December 5, 2017
·
3 min read
·
Mark Terry
Business
79 Employees Affected as Novartis Plans Shut Down of UK Site
Novartis told Kent Online that the reason the company is looking at closing the facility is the rapid advancements in point of care diagnostic devices.
December 5, 2017
·
2 min read
·
Alex Keown
Biotech Bay
Apple Works on Tackling Heart Disease With New Study
A new application for its Apple Watch could save thousands of lives.
December 5, 2017
·
1 min read
Business
Hill-Rom to Shutter Tridien Medical’s Indiana Facility, 69 Jobs Affected
The first round of Indiana employees are expected to be let go January 31 and continue through the end of September.
December 5, 2017
·
1 min read
Business
OptiBiotix Appoints Experienced Food Industry Executive Neil Davidson as New Chairman
Experienced food industry executive Neil Davidson has been appointed as non-executive Chairman of OptiBiotix.
December 5, 2017
·
2 min read
Business
San Diego’s Vital Therapies Names Ex-Jazz Pharma Exec as New Chief Leader
Cox takes over for Vital Therapies CEO Terry Winters who will step down from the Vital Therapies Board and become a consultant to the company.
December 5, 2017
·
2 min read
·
Alex Keown
Business
What You Need to Know About Boragen
Boragen is located in Research Triangle Park in Durham, N.C., and focuses on boron-based development of anti-bacterials and anti-fungicides for the agricultural industry.
December 5, 2017
·
5 min read
Business
What You Need to Know About CARMA Therapeutics
CARMA Therapeutics is based on technology from the Center for Cellular Immunotherapies at the University of Pennsylvania, and was spun out of the laboratory of Saar Gill, assistant professor of Hematology Oncology in the Perelman School of Medicine there.
December 5, 2017
·
4 min read
·
Mark Terry
Business
What You Need to Know About Cirius Therapeutics
With headquarters located in San Diego, Calif. and Kalamazoo, Mich., Cirius Therapeutics is a clinical-stage pharmaceutical company focused on developing a treatment for NASH.
December 5, 2017
·
6 min read
·
Mark Terry
Previous
17 of 17